This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Law Offices Of Ronald A. Marron, APLC Announces Preliminary Approval Of Class Action Settlement

SAN DIEGO, Feb. 20, 2013 /PRNewswire/ -- The following statement is being issued by the Law Offices of Ronald A. Marron, APLC pursuant to an order of the United States District Court for the Southern District of California:

CONSUMER CLASS ACTION SETTLEMENT REACHED WITH HUMPHREYS PHARMACAL, INCORPORATED AND DICKINSON BRANDS INC.

A settlement has been reached in a proposed nationwide consumer class action lawsuit filed in the Southern District of California in San Diego entitled Nigh v. Humphreys Pharmacal, Incorporated and Dickinson Brands Inc. The plaintiff, Melissa Nigh, is represented by the Law Offices of Ronald A. Marron, APLC. Humphreys and Dickinson are represented by the law firms of Robinson & Cole LLP and Sheppard, Mullin, Richter & Hampton LLP.

The proposed settlement is subject to court approval and would provide for a fund of $1.4 million to which claims for rebates may be submitted for purchases since June 20, 2008 of any of Humphreys products labeled as homeopathic, including Arthritis Relief, Bedwetting Pellets, Cold Relief, Colic Pellets, Cough Control, Insomnia Relief, Simple Diarrhea, Simple Fever, Simple Nervous Conditions, Symptoms of Delayed Menses, Teething Pellets, and Teething Strips.

In the lawsuit, Ms. Nigh claims that Humphreys made misleading and confusing claims about the efficacy and ingredients of its homeopathic products. Ms. Nigh and Humphreys, through their counsel, engaged in lengthy negotiations, including formal mediation, to arrive at settlement terms that will address Ms. Nigh's claims. Those terms include adding disclaimers on the products' packaging that state: "These 'Uses' have not been evaluated by the Food and Drug Administration," and "'X' is a homeopathic dilution. For more information, see www.HumphreysClassActionSettlement.com," which will refer customers to a designated Humphreys website for details. These disclaimers and other measures will be made a formal part of the settlement upon court approval. In addition, as a part of the settlement, Humphreys has agreed not to label its homeopathic products as "natural" or "all natural" if they contain synthetic ingredients, and not to claim "no animal ingredients" on products containing, for example, extremely small quantities of derivatives of cuttlefish and certain beetles as ingredients.

Humphreys and Ms. Nigh believe that these measures, including revision of Humphreys' Products' labels, will help consumers have necessary information about Humphreys' products and how homeopathic products work in general.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,919.59 +80.85 0.48%
S&P 500 1,981.60 +9.86 0.50%
NASDAQ 4,527.5140 +19.2020 0.43%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs